Back
Zai Lab Vs. NovoCure Industry Stock Comparison
Buy
68
ZLAB
Zai Lab
Last Price:
$40.59
Seasonality Move:
8.3%
Sell
25
NVCR
NovoCure
Last Price:
$17.90
Seasonality Move:
2.37%
Sell
25
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ZLAB Stock Price Chart
NVCR Stock Price Chart
ZLAB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.69 | Buy |
Relative Strength Index (14 RSI): | 69.02 | Buy |
Chaikin Money Flow: | -580771 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 48.71 | Sell |
Chaikin Money Flow: | -343847 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
ZLAB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.25 | Buy |
20-day SMA: | 34.6 | Buy |
50-day SMA: | 31.98 | Buy |
200-day SMA: | 28.77 | Buy |
8-day EMA: | 39.12 | Buy |
20-day EMA: | 35.79 | Buy |
50-day EMA: | 33.43 | Buy |
200-day EMA: | 29.34 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.32 | Buy |
20-day SMA: | 17.91 | Sell |
50-day SMA: | 17.45 | Buy |
200-day SMA: | 20.18 | Sell |
8-day EMA: | 17.62 | Sell |
20-day EMA: | 17.71 | Sell |
50-day EMA: | 18.09 | Sell |
200-day EMA: | 19.92 | Sell |
Zai Lab Earnings Growth & ZLAB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.43 per share, an increase this year of $1.29 per share, and an increase next year of $1.54 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.35 per share, and a decrease next year of $0.10 per share.
Zai Lab Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |